DUBLIN, Ohio, Dec. 7 /PRNewswire-FirstCall/ -- Cardinal Health today announced that the U.S. Drug Enforcement Administration (DEA) has suspended its license to distribute controlled substances from its Lakeland, Fla. distribution center, effective Dec. 10 .
To ensure continuity of service, the company is making arrangements to distribute controlled substances to affected customers from other facilities within its network of 25 pharmaceutical distribution centers.
Chairman and Chief Executive Officer R. Kerry Clark said: "Anything less than best-in-class controls for the pharmaceutical supply chain is unacceptable. We will do what it takes to address this execution issue with changes to our processes and systems. The security of the pharmaceutical supply chain is core to our business and we are committed to the highest standards as we work with the DEA to resolve this matter."
Cardinal Health has been reviewing its controlled substance procedures, and as a result is implementing near- and long-term enhancements that further guard against distribution to pharmacies engaged in diversion.
About Cardinal Health
Headquartered in Dublin, Ohio, Cardinal Health , Inc. (NYSE: CAH) is an
SOURCE Cardinal Health , Inc.